About Quibim S.L.
Quibim S.L. is a leading healthcare AI company specializing in the development of advanced imaging biomarkers and artificial intelligence solutions for the life sciences. The company’s mission is to transform medical images into actionable predictions, thereby enhancing diagnostic accuracy, guiding treatment decisions, and accelerating drug development programs. Quibim’s cloud-based platform, Quibim Precision®, is a whole-body imaging ecosystem that processes and analyzes medical images (MRI, CT, PET scans) to extract quantitative imaging biomarkers. This platform is designed to support clinicians and researchers by providing objective measurements of disease changes, identifying subtle health indicators often invisible to the human eye, and harmonizing imaging data to minimize variability across different equipment.
For physicians, Quibim’s AI-powered tools, such as QP-Prostate®, QP-Brain®, and QP-Liver®, offer significant advancements in disease detection and management. QP-Prostate®, for instance, is an FDA-cleared and CE/UKCA marked solution that automates prostate gland segmentation, identifies suspected lesions based on pathology data, and streamlines reporting for prostate cancer diagnosis. The company’s technology aims to integrate seamlessly into radiology workflows, reducing workload, improving diagnostic confidence, and facilitating personalized medicine by predicting patient responses to treatments and optimizing clinical trial enrollment. Quibim also collaborates with biopharmaceutical companies to advance drug discovery and monitor treatment efficacy through its imaging biomarker expertise and real-world evidence studies.
Focus Areas
Business Intelligence
| Key Investors | Asabys, Buenavista Equity Partners, Amadeus Capital Partners, Apex Ventures, Partech, UI Investissements, GoHub Ventures, Adara Ventures, Leadwind (KFund), Tony Fadell, Dr. Jonathan Milner, Columbus Venture Partners |
| Partnerships | Philips (MRI scanners), Merck KGaA (precision medicine, cancer, immunotherapy), Novartis, ImaginAb (immunotherapy response), Microsoft (virtual biopsies, Azure), Alma Medical (distribution), Ferrum Health (oncology ecosystem platform deployment), Vara (breast cancer screening AI in Spain) |
| Technology | Cloud-based, AI-powered imaging platform (Quibim Precision®), QP-Insights (data management, harmonization, multi-omics, EHR integration), tissue-agnostic, deep learning, radiomics, ISO 27001:2022 certified, HIPAA and GDPR compliant, Microsoft Azure cloud platform |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, Quibim's solutions offer several key advantages:nn* **Enhanced Diagnostic Confidence & Accuracy:** AI algorithms identify subtle patterns and provide quantitative data often invisible to the human eye, leading to earlier and more precise diagnoses in conditions like prostate cancer, brain atrophy, and liver diseases.n* **Streamlined Workflow & Efficiency:** Automated tasks such as image quality assessment (AI-QUALu2122 for prostate MRI), organ/lesion segmentation, and quantitative reporting significantly reduce manual effort and optimize radiology workflows, allowing more time for complex cases.n* **Objective & Standardized Reporting:** Provides objective, measurable insights (e.g., brain volumetry, fat/iron quantification) and structured reports compliant with clinical standards (e.g., PI-RADS for prostate), reducing subjectivity and improving consistency across readings.n* **Early Disease Detection & Monitoring:** Tools like QP-Brain enable earlier identification of neurodegenerative diseases and objective longitudinal tracking of disease progression, facilitating timely interventions and personalized patient management.n* **Support for Precision Medicine:** The ability to extract imaging biomarkers and integrate multi-omics data aids in patient stratification, predicting treatment response, and tailoring treatment plans to individual patient needs.n* **Seamless Integration:** Quibim's products are designed for easy integration with existing Picture Archiving and Communication Systems (PACS) and Electronic Health Record (EHR) systems, minimizing disruption to current clinical practice.n* **Regulatory Compliance & Data Security:** With FDA, CE, and UKCA clearances, and adherence to ISO 27001, HIPAA, and GDPR, physicians can trust the reliability and security of the data and diagnostic tools.
Quibim's platforms and products are designed for seamless integration within existing healthcare IT infrastructures. Key integrations include:n* **PACS (Picture Archiving and Communication Systems):** Direct integration for automatic transfer of images and reports, streamlining radiological workflows.n* **EHR (Electronic Health Records):** Ability to link imaging data with EHR information and other multi-omics techniques for comprehensive patient insights.n* **Cloud Platforms:** Utilizes Microsoft Azure for secure and scalable data storage and processing.n* **Imaging Equipment Vendors:** Strategic partnerships, such as with Philips, to integrate Quibim's AI models directly into MRI technology for enhanced diagnostic capabilities.
What the Web Says
Quibim S.L. is a European health-tech company founded in late 2012, specializing in AI-driven precision medicine. They develop AI tools that analyze medical images (MRI, CT, PET) to extract quantitative imaging biomarkers, aiding in disease detection, monitoring, and treatment evaluation. Their technology is used in clinical practice, research projects, and clinical trials, with a presence in over 230 healthcare institutions worldwide.
Overall: PositiveStrengths
- AI-powered quantitative imaging solutions for improved diagnosis and patient follow-up.
- Precision platform for centralized storage, management, and advanced analysis of medical images.
- FDA 21 CFR Part 11 compliant, ensuring data security and regulatory compliance (HIPAA, GDPR, ISO 27001:2022 certified).
- Interoperable platform, offering both local installation and cloud-based service.
- Collaborative, scientific, and mission-driven company culture with an emphasis on innovation and improving patient outcomes.
- Offers career development opportunities, including training, conference attendance, and mentorship programs.
Limitations
- No specific product or employer cons were found on the searched platforms (G2, Glassdoor, Capterra, Reddit).
- General concerns about AI accuracy in medical imaging exist, though not specifically directed at Quibim.
- The comparison of Quibim's brain atrophy screening module with another software showed moderate diagnostic agreement, though accuracy, sensitivity, and specificity were not significantly different between the packages.
Based on reviews from: Decide Advisory Services, ReviewAI, Quibim (Official Website), EUJobs.co, Reddit, PMC (PubMed Central)
Last updated: 2026-07-19
Videos
News, demos, and interviews about Quibim S.L..
Videos load interactively. If none appear, search YouTube for Quibim S.L. →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Quibim S.L..
Comparisons
For a physician evaluating AI tools for prostate MRI interpretation, Quantib Prostate and QUIBIM Precision Prostate (qp-Prostate) both offer FDA-cleared solutions to enhance diagnostic workflows. Quantib Prostate excels in providing advanced tools for segmentation, PI-RADS scoring, and standardized reporting, with a strong emphasis on visual support for PI-RADS v.2.1 and kinetic curve representation. It is […]
When considering AI tools for prostate MRI interpretation, physicians have two options from Quibim S.L.: QP-Prostate® CAD and QUIBIM Precision Prostate (qp-Prostate). Both are FDA-cleared and aim to enhance diagnostic accuracy and streamline radiology workflows for prostate cancer detection. Both tools offer automated prostate segmentation, AI-driven lesion detection, and PI-RADS compliant reporting, along with AI-QUAL™ […]
When choosing between QUIBIM Precision Prostate (qp-Prostate) and ProstatID, physicians should consider their existing infrastructure and specific workflow needs. qp-Prostate excels in comprehensive prostate MRI interpretation, offering automated segmentation, AI-driven lesion detection, and PI-RADS compliant reporting. It also provides advanced features like automated image quality assessment (AI-QUAL™) and support for fusion and focal therapy planning. […]
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]